Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction

QR Code

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction

Francisco José Muñoz Negrete,1 Hans G Lemij,2 Carl Erb3 1Ophthalmology Service, Hospital Ramón y Cajal, Madrid, Spain; 2Glaucoma Service, Rotterdam Eye Hospital, Rotterdam, the Netherlands; 3Augenklinik Wittenbergplatz, Berlin, Germany Abstract: Patient satisfactio...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Muñoz Negrete FJ, Lemij HG, Erb C
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2017
Sujets:	Prostaglandins analogs glaucoma therapy preservative patient satisfaction tolerability persistence tear substitutes. Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/f034b2d2b534446d965f06d8d8a2ff5e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
par: Erb C, et autres
Publié: (2021)

Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
par: Stalmans I, et autres
Publié: (2020)

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
par: Economou MA, et autres
Publié: (2018)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum]
par: Muñoz Negrete FJ, et autres
Publié: (2017)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
par: Beck DER, et autres
Publié: (2017)

Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
par: García-Feijoo J, et autres
Publié: (2016)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
par: Ruangvaravate N, et autres
Publié: (2020)

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
par: Lo JS, et autres
Publié: (2016)

Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
par: Tamçelik N, et autres
Publié: (2017)

Improving patient satisfaction in glaucoma care
par: Islam S, et autres
Publié: (2017)

Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice
par: Pfennigsdorf S, et autres
Publié: (2016)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
par: Radcliffe N, et autres
Publié: (2020)

Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
par: Uusitalo H, et autres
Publié: (2016)

Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study
par: Feldman RM, et autres
Publié: (2020)

Glaucoma therapy: preservative-free for all?
par: Thygesen J
Publié: (2018)

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
par: Pillunat LE, et autres
Publié: (2017)

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
par: Hiromitsu Onoe, et autres
Publié: (2021)

Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
par: Addis VM, et autres
Publié: (2018)

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease
par: Nasser L, et autres
Publié: (2018)

Tolerant, Growing Cells from Nutrient Shifts Are Not Persister Cells
par: Jun-Seob Kim, et autres
Publié: (2017)

Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
par: Pillunat LE, et autres
Publié: (2016)

Areas and factors associated with patients’ dissatisfaction with glaucoma care
par: Foo VH, et autres
Publié: (2017)

Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
par: Kozobolis V, et autres
Publié: (2018)

Fertility Preservation: How to Preserve Ovarian Function in Children, Adolescents and Adults
par: Marie-Madeleine Dolmans, et autres
Publié: (2021)

A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
par: Stevens A, et autres
Publié: (2016)

Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination
par: Inoue K, et autres
Publié: (2020)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
par: Nakano T, et autres
Publié: (2016)

Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma
par: Siddiqui M, et autres
Publié: (2019)

Cytokine biomarkers in tear film for primary open-angle glaucoma
par: Gupta D, et autres
Publié: (2017)

Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon
par: Shen J, et autres
Publié: (2016)

Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
par: Takagi Y, et autres
Publié: (2018)

Effectiveness of Netarsudil as an Additional Therapy for Glaucoma in Patients Already on Maximally Tolerated Medical Therapy
par: Villegas NC, et autres
Publié: (2021)

Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication
par: Lindstrom R, et autres
Publié: (2020)

Patient Satisfaction Determinants of Inpatient Healthcare
par: Beata Gavurova, et autres
Publié: (2021)

Influence of Maternal Satisfaction with the Dentist in Children's Oral Care: Cross-Sectional Study
par: Rigo,Lilian, et autres
Publié: (2019)

Assessment of the Patients\' Satisfaction about the Education Received from Their Physicians in Babol City
par: Ali ShabestaniMonfared, et autres
Publié: (2015)

Prostaglandins

THE RESEARCH OF RELATIONSHIP BETWEEN PATIENT SATISFACTION, PATIENT LOYALTY AND DEMOGRAPHIC FACTORS
par: İbrahim Çetintürk
Publié: (2019)

Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells
par: Alexander Harms, et autres
Publié: (2017)

Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test
par: Özyol P, et autres
Publié: (2016)